Epigenetic inactivation of the hsa-miR-203 in haematological malignancies

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 12, 2011, Pages 2760-2767

  Chim, Chor Sang ^a   Wong, Kwan Yeung ^a   Leung, Chung Ying ^b   Chung, Lap Ping ^a   Hui, Pak Kwan ^c   Chan, Sau Yan ^a   Yu, Li ^d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c KWONG WAH HOSPITAL   (Hong Kong)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Hypermethylation; Leukaemia; Lymphoma; MicroRNA; Tumour suppressor

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN203 MICRORNA, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DISEASE; CASE CONTROL STUDY; CELL PROLIFERATION; CLASSIFICATION; COMPARATIVE STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE SILENCING; GENETICS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; YOUNG ADULT;

EID: 82155184350     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01274.x     Document Type: Article

References (24)

1. Chim CS, Liang R, Kwong YL. Hypermethylation of gene promoters in hematological neoplasia. Hematol Oncol. 2002; 20: 167-76.
2. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003; 349: 2042-54.
3. Chim CS, Fung TK, Liang R. Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS. Leukemia. 2003; 17: 2533-5.
4. Chim CS, Wong ASY, Kwong YL. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol. 2005; 80: 282-7.
5. Chim CS, Fung TK, Cheung WC, et al. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Blood. 2004; 103: 4630-5.
6. Chim CS, Wong ASY, Kwong YL. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Ann Hematol. 2004; 83: 527-32.
7. Chim CS, Kwong YL, Liang R. Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach. Clin Lymphoma Myelom. 2008; 8: 331-9.
8. Chim CS, Pang R, Fung TK, et al. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia. 2007; 21: 2527-36.
9. Chim CS, Liang R, Fung TK, et al. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/ p53/Apaf-1 apoptosis pathway in multiple myeloma. J Clin Pathol. 2007; 60: 664-9.
10. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-69.
11. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005; 353: 1768-71.
12. Bueno MJ, Perez de Castro I, Gomez de Cedron M, et al. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 2008; 13: 496-506.
13. Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010; 31: 766-76.
14. Bennett JM, Catovsky D, Marie-Theregse D, et al. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group. Br J Haematol. 1976; 33: 451-8.
15. Van den Berghe H. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol. 1988; 68: 487-94.
16. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111: 5446-56.
17. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
18. Chim CS, Liang R, Fung TK, et al. Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma. Leukemia. 2005; 19: 2352-5.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods. 2001; 25: 402-8.
20. Lujambio A, Esteller M. CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle. 2007; 6: 1455-9.
21. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. PNAS. 2008: 105; 13556-61.
22. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004; 103: 216-21.
23. Siu LL, Chan JK, Wong KF, et al. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas. Br J Haematol. 2003; 122: 70-7.
24. Chim CS, Wong KY, Qi Y, et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis. 2010; 31: 745-50.